Evidence map›Paper›PMID 41647629›Full record

ArticleiGIE : innovation, investigation and insights2023

Hybrid versus conventional endoscopic submucosal dissection for treatment of gastric lesions: a comparative systematic review and meta-analysis.

Thomas R McCarty, Ahmad Najdat Bazarbashi, Michael Senter-Zapata, Russell D Dolan, Christopher C Thompson, Hiroyuki Aihara

Abstract read
In one paragraph

Article in iGIE : innovation, investigation and insights, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas R McCartyLynda K. and David M. Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas, USA.
Ahmad Najdat BazarbashiDivision of Gastroenterology and Hepatology, School of Medicine, Washington University, St Louis, Missouri, USA.
Michael Senter-ZapataDepartment of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Russell D DolanDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Christopher C ThompsonDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hiroyuki AiharaDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Hybrid endoscopic submucosal dissection (ESD) may overcome the complexity of conventional ESD associated with gastric lesions. The aim of this study was to perform a systematic review and meta-analysis to compare the efficacy and safety of hybrid versus conventional ESD for the treatment of gastric lesions. Methods: Individualized search strategies were developed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. Pooled proportions were calculated with rates estimated using random-effects models. Measured outcomes included en-bloc resection, procedure-associated adverse events, and procedure duration. Heterogeneity was assessed with the Results: Of 5 included comparator studies (hybrid ESD, 184 patients; conventional ESD, 289 patients), 1 was a randomized trial and 4 were retrospective observational studies. Mean patient age was 68.89 ± 4.75 years, and the average lesion size was 17.81 ± 5.58 mm. Hybrid ESD patients were older ( Conclusions: Although hybrid ESD for gastric lesions was associated with significantly shorter procedure times compared with conventional ESD, hybrid ESD was associated with lower rates of en-bloc resection and similar adverse events.

Identifiers

PMID41647629
PMCPMC12850856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.